1. Imalux® Names New President/CEO

    CLEVELAND--(BUSINESS WIRE)--Imalux Corporation (“Imalux”), a medical device company and developer of the Niris® Imaging System based on Optical Coherence Tomography (“OCT”) technology,
    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks

    1. We are very pleased to have Mike assume the leadership role at Imalux. He has a track record of success in all phases of commercialization of medical technologies on a worldwide basis. In addition to his extensive experience in the health care imaging industry, Mike has an impressive combination of proven entrepreneurial and executive management skills with a diversified background ranging from start-ups to Fortune 100 companies. Mike is extremely well qualified to direct the Company through our next stages of accelerated growth.
    2. Following my TREK experience, I was looking at several opportunities for my next venture. As I did my due diligence on Imalux, I was greatly impressed by the strength and commitment of the Imalux team, the Company's proprietary and proven technology, their excellent clinical validation studies, and, importantly, positive feedback from physicians using the Niris system. This combination indicates to me that the Company is well positioned to become a leader in the exciting and expanding OCT imaging market.
  3. Topics Mentioned